//Generics --> https://generics.citeline.com

Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

About Generics Bulletin


Unrivalled coverage, news and analysis of the global generics, biosimilars and value-added medicines industries.

A well-respected and trusted industry source for the last 15 years, Generics Bulletin from Pharma Intelligence provides in-depth news and analysis on issues that matter most to businesses across the generics, biosimilars and value-added medicines industries.

From business strategies, mergers and acquisitions, to manufacturing compliance, pricing and reimbursement, legislative moves, patent litigation and product launches, Generics Bulletin has you covered. Providing accurate and reliable news reports, combined with our experts’ insight and opinions, and revealing the latest strategies and the business performance of the world’s leading generics and biosimilar companies.

Read by senior executives in all of the world’s leading generics companies, as well as industry watchers, and those supplying active ingredients, and goods and services to these fast-moving and rapidly expanding industries, you can rely on this industry leading source to understand and anticipate the latest market, policy and regulatory and commercial developments critical for success by preparing you for challenges, and helping you to minimize risks and maximize growth opportunities.



Researched and written by a team of generics, biosimilar and value-added medicines specialists who provide first-hand coverage of key events from locations around the globe. Sources and readers alike trust our coverage as independent, thorough and objective, thanks to our 15-year track record of excellence.


More than just news, keeping you up-to-date, and giving you the implications, trends, and actionable insights to provide a deeper look at what’s really behind the headlines, and how it might impact your business, now and in the future.


If you have a question about any of our news stories, analysis or data, or indeed about any market or business issues that you face, Ask the Analyst! This unique service provides a direct connection to our expert journalists and analysts to answer your questions on our news content and your research and business critical questions.


New user-friendly, digital platform that is responsive to any mobile device and includes robust, boolean search and content customization tools like My View and custom alerts, targeted to your specific content needs and priorities.


Your generics, biosimilars and value-added medicines questions answered

  • Which geographic regions, product categories and dosage forms are key players targeting?
  • Who is up for sale, and who is buying?
  • How are companies ensuring manufacturing compliance, and who is falling short?
  • Whose sales and profits are on the rise, and who is struggling?
  • Which top executives are making a move, and who is recruiting?
  • How are the latest regulatory changes affecting the current operating environment?
  • Where are the most attractive locations to launch and get a return on investment?
  • What litigation strategies are paying off, and who is suing whom where?
  • Which markets and categories are booming?
  • Who is looking for partnerships to develop and market generic, biosimilar and value-added medicines?
  • Where are the next pipeline opportunities coming from?

Your generics, biosimilars and value-added medicines questions answered

  • Exclusive in-depth interviews with the key decision-makers in the global generics, biosimilars and value-added medicines industries
  • Detailed analyses of company strategies, pipelines and prospects
  • Pipeline Watch: Opportunities arising from key intellectual-property events around the world, powered by IQVIA’s Ark patent-intelligence database
  • Price Watch: Up-to-date pricing information and trends for the UK pharmacy market, based on exclusive data supplied by market researcher WaveData


ASK THE ANALYST: Exclusive service where our clients can ask our expert journalists and analysts questions about any of our news stories, data and analysis when they need additional information.


Video, audio, and proprietary data sets bring our articles and analyses to life.

Numerous search filters allow for precise content targeting, and articles and searches can be saved and shared with one-click

Set custom email alerts on any topic or search criteria so you never miss what you need to know most.